Supriya Peshin/X
Jun 4, 2025, 09:59
Supriya Peshin: ASCO25 – Spotlight on SC Anal Cancer and the Push for Innovation
Supriya Peshin, Visiting Resident in Hematology and Oncology at MD Anderson Cancer Center, shared a post on X:
“Once overshadowed in oncology discourse, SC anal cancer is now commanding attention, driven by the rise in HPV-associated cases and the unmet need in therapeutic innovation.
At ASCO25, the spotlight intensifies:
Immunogenomic profiling
HIV+ patient outcomes
Retifanlimab trials
Genomic-guided targeted therapy
This year’s robust presence of SCAC research signals a call to action to raise awareness, accelerate discovery, and champion equity in care for this often neglected malignancy.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 7, 2025, 05:55
Sep 7, 2025, 05:46
Sep 7, 2025, 05:24
Sep 7, 2025, 05:18
Sep 7, 2025, 05:14
Sep 7, 2025, 05:09
Sep 7, 2025, 05:05
Sep 7, 2025, 04:54
Sep 7, 2025, 04:53
Sep 7, 2025, 04:42